Nuo Therapeutics Inc NUOTQ Financial and Strategic SWOT Analysis Review [Report Updated: 05072017] Prices from USD $125

11:30 EDT 2 Aug 2017 | BioPortfolio Reports

Nuo Therapeutics Inc NUOTQ Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Nuo Therapeutics Inc Nuo Therapeutics is a biomedical company, which specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cellbased technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company's flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient's innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has an office in Nashville, Tennessee; and a facility in Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc Key Recent Developments

Mar 29,2016: Nuo Therapeutics Provides Update on Chapter 11 Bankruptcy Process and Proposed Plan of Reorganization
Jan 26,2016: Nuo Therapeutics Commences Voluntary Chapter 11 Business Reorganization
Jan 12,2016: Nuo Therapeutics Announces Senior Management Change and Provides Limited Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Nuo Therapeutics Inc NUOTQ Financial and Strategic SWOT Analysis Review [Report Updated: 05072017] Prices from USD $125


More From BioPortfolio on "Nuo Therapeutics Inc NUOTQ Financial and Strategic SWOT Analysis Review [Report Updated: 05072017] Prices from USD $125"

Quick Search

Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...